🇺🇸 Federal Cannabis Rescheduling Could Accelerate Industry Mergers and Acquisitions

A new industry analysis argues that federal rescheduling is likely to drive increased merger and acquisition activity across the cannabis sector as companies position themselves for a more regulated and competitive market. The author suggests that pharmaceutical, agricultural and other large corporations may begin viewing cannabis businesses as attractive acquisition targets, particularly those with strong brands, licenses or operational advantages. Rather than creating an immediate nationwide market, rescheduling may speed up the process of determining which companies emerge as consolidators and which become acquisition candidates. The article encourages cannabis operators to evaluate whether they are positioned to grow independently, acquire competitors or capitalize on potential buyout opportunities as the industry evolves. (Marijuana Moment)

🎗️ Researchers Identify Cannabinoid Receptor That May Help Reduce Breast Cancer Aggressiveness

Researchers studying breast cancer found that briefly targeting the body's CB2 cannabinoid receptor with ultra-low doses of THC reduced traits associated with aggressive tumor growth in laboratory-grown tumor models and mice. The treatment appeared to decrease cancer cell invasiveness, self-renewal and tumor-forming ability, suggesting it may help limit the spread and progression of certain breast cancers. Scientists believe the effect is primarily linked to the CB2 receptor, which is involved in immune and inflammatory responses rather than the psychoactive effects associated with cannabis. While the findings are promising, the research remains in preclinical stages, and much more work is needed before any potential cancer treatment could be tested or used in patients. (Sciencealert)

📼 DEA Judge Orders Corrections to Marijuana Rescheduling Hearing Transcript

The DEA judge overseeing the federal marijuana rescheduling proceedings has ordered dozens of corrections to the official hearing transcript, with a finalized version scheduled for public release after the revisions are incorporated. The corrections include technical errors, speaker identifications and several substantive wording changes that could affect how portions of the testimony are interpreted. The order also revealed that the hearing record spans at least 2,470 pages, underscoring the scope of the evidence reviewed during the rescheduling process. The updated transcript is expected to become part of the official record as federal officials continue evaluating whether marijuana should move from Schedule I to Schedule III under federal law.

👉 Read The Full Study Here

🌎 California Loses Title as World’s Largest Legal Cannabis Market as Sales Continue to Struggle

A new report says California is no longer the world’s largest legal cannabis market, with Canada recently surpassing the state in legal cannabis sales. Industry observers attribute California’s decline to a combination of high taxes, limited retail access in many communities and persistent competition from the illicit market, which has continued to thrive despite legalization. More than half of California cities and counties still prohibit licensed cannabis retailers, limiting consumer access to the regulated market. The report argues that these structural challenges have weakened legal sales and made it more difficult for California’s cannabis industry to maintain its global leadership position. (SFGate)

🗓️ Continued Cannabis News & Events

• As DEA Rules Marijuana's Medical Status, Cannabis Giants Face RICO Claims-and Insurers Head for the Exits

• More Than 200,000 People Were Arrested For Marijuana Possession In The U.S. Last Year, FBI Data Shows

• More people killed in Connecticut crashes had cannabis in their systems after legalization: Study

• Canada still dominates global cannabis exports, but changes are coming fast